ASX Announcements
Market Sensitive
Investor Presentation - The Microcap Conference USA
Company Presentation
- Jan 29, 2025
- 18 pages
Market Sensitive
December 2024 Quarterly Activity Report and Appendix 4C
CTE – Fourth Quarter Cashflow Report, CTE - Fourth Quarter Activity Report
- Jan 24, 2025
- 6 pages
Initial Director's Interest Notice - Peter Mullin
Initial Director’s Interest Notice
- Jan 17, 2025
- 2 pages
Initial Director's Interest Notice - John Sharman
Initial Director’s Interest Notice
- Jan 17, 2025
- 2 pages
December 2014
The biggest biotechnology blunders of 2014
Biotechnology investors understand that their appetite for speculation brings both risk and reward, but it is likely that even the bravest stockpickers will be happy to leave 2014 behind.
- Updated
- Jessica Gardner
November 2012
- Opinion
Universal Biosensors raises $12m
Listed medical diagnostics company Universal Biosensors is raising $12 million through Wilson HTM and Veritas Securities.
- Sarah Thompson and Anthony Macdonald
February 2012
Biotechs making a steady recovery
There is likely to be a sharp pick-up in interest in Australian biotechs this year as they move into their next phase of growth, which will pave the way for them to be taken over by global drug companies.
- Updated
- Brendon Lau
September 2011
Companies briefs
Ivanhoe Australia has raised $88 million after completing the institutional component of a $180 million share issue.
- Updated
- Luke Forrestal
February 2011
Universal Biosensors (UBI)
The specialist medical diagnostics company’s shares touched a three month high of $1.62 on Monday, but have since plunged over 10 per cent.
- Updated
September 2010
Bidders get busy as sale of SAE gets closer
It seems the sale process of audio education provider SAE is nearing the pointy end of proceedings.
March 2010
Old blood pumps up skills
A key reason why Silicon Valley works as a crucible of innovation is the complex interactions of technologists, company directors, managers, marketers and financiers who work in the area and who have “done it all before”.
- Updated
- Peter Roberts
December 2009
Profit surge expected for Universal Biosensors
Shares in Universal Biosensors are not far off last month’s record high of $1.98 after the company said it had shipped its first commercial order of blood glucose strips and received a milestone payment of $16 million from its partner LifeScan.
- Updated
- Brendon Lau
July 2009
Universal Biosensors' strip tease
After slumping 70 per cent from their peak, shares in Universal Biosensors have roared back to life as investors reassess the company's earnings potential
- Tony Featherstone